Company Filing History:

12 out of 3,684

Bristol-myers Squibb Compnay

patents

2 out of 637

Bristol-myers Company

patents

1 out of 796

Florida State University Research Foundation, Inc.

patents

where one patent can have more than one assignee

Years Active: 1989-1997

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5693666 - 6,7-modified paclitaxels (1997-12-02),

2. 5478854 - Deoxy taxols (1995-12-26),

3. 5380751 - 6,7-modified paclitaxels (1995-01-10),

4. 5350866 - 10-desacetoxytaxol derivatives (1994-09-27),

5. 5300638 - Asymmetric synthesis of taxol side chain (1994-04-05),

6. 5294637 - Fluoro taxols (1994-03-15),

7. 5272171 - Phosphonooxy and carbonate derivatives of taxol (1993-12-21),

8. 5254580 - 7,8-cyclopropataxanes (1993-10-19),

9. 5248796 - Taxol derivatives (1993-09-28),

10. 5162524 - Processes for making cephems from allenylazetidinone derivatives (1992-11-10),

11. 5162521 - Processes for making cephems from allenylazetidinone derivatives (1992-11-10),

12. 5011774 - Dideoxyinosine by enzymatic deamination of dideoxyadenosine (1991-04-30),

13. 4870168 - 3-Unsaturated alkyl cephems from 3-triflyl cephems (1989-09-26),

14. 4847373 - Production of 3-allyl- and 3-butenyl-3-cephems (1989-07-11),

Title: The Innovative Mind of Vittorio Farina: A Pioneer in Pharmaceutical Patents

Introduction: Vittorio Farina, an accomplished inventor based in West Hartford, CT, has made significant contributions to the field of pharmaceuticals. With a portfolio of 14 patents, Farina's work has focused on innovative compounds that hold the potential for enhancing therapeutic effects in medicine. His latest breakthroughs demonstrate his commitment to advancing medical science through inventive solutions.

Latest Patents: Among Farina's most recent patents are the "6,7-modified paclitaxels," which provide new derivations of paclitaxel along with pharmaceutical compositions designed to improve treatment efficacy. Another noteworthy creation is the "Deoxy taxols," where the formulation includes specific derivatives aimed at enhancing the therapeutic properties of taxols. These patents exemplify Farina’s innovative approach to addressing medical needs through chemical modifications.

Career Highlights: Farina has had a distinguished career in the pharmaceutical industry, working with renowned organizations such as Bristol-Myers Squibb Company and Bristol-Myers Company. His extensive experience and expertise have allowed him to navigate complex scientific challenges and contribute to vital health solutions through his inventions.

Collaborations: Throughout his career, Farina has collaborated with prominent colleagues like Shu-Hui Chen and Dolatrai M Vyas. These partnerships have fostered a vibrant exchange of ideas and have led to the development of new concepts in pharmaceutical research, further enhancing the impact of their combined efforts.

Conclusion: Vittorio Farina stands out as a visionary inventor in the pharmaceutical field. With a robust patent portfolio and a history of collaboration with industry-leading companies and researchers, his innovative contributions continue to pave the way for advancements in medical therapeutics. Farina's dedication to developing new pharmaceutical solutions reflects the potential of inventive thinking to transform healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com